Viewing Information

Program Summary

Open MRI Systems have evolved enormously since their inception in the 1980’s and today true high-field systems offer an excellent, patient centric alternative to closed, cylindrical bore systems for imaging of basic and advanced applications throughout the body.

In this final installment of this 2-Part series, which is being chaired and moderated by Dr. Lawrence N. Tanenbaum, we will hear from Dr. John Feller who will address the advantages of high-field open MRI systems for MSK imaging. Specifically, he will cover patient comfort, image quality, isocentric imaging, metal artifact reduction scanning (MARS), solenoid coil technology, fat suppression, operational efficiency, and marketability.

Following the presentation, Dr. Tanenbaum will moderate a live Q&A where questions from the audience will be addressed.

Effective Date: September 19, 2017
CME Expiration Date: September 18, 2019
CE Expiration Date: November 30, 2019
Format: Self Instructional - Audio Visual with Slides
Educational Credits:
One (1) AMA/PRA Category 1 CME Credit™
One (1) ARRT Category A CE Credit.
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour

This program was originally broadcast live as part of a webinar sponsored by IAME and supported through an unrestricted educational grant from Hitachi Healthcare Americas

Target Audience & Cost

This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.

There is no cost to participate in this program.

Educational Objectives

Upon completion of this CME activity the healthcare provider should be able to:

1. Describe how market forces including patient centric imaging are impacting today’s radiology departments.
2. Describe how modern Open MRI Systems align with value-based care and are changing the way that imaging facilities do business.
3. Understand the technical specifications of High-Field Open MRI Systems.
4. Understand the concept of isotropic imaging and new fat suppression technologies.
5. Describe the increased image quality and range of applications in MSK imaging.

No special educational preparation is required for this CME/CE Activity!

Speakers

John F. Feller, MD
Medical Director & Founder
Desert Medical Imaging

Dr. John F. Feller is a founding partner of Desert Medical Imaging, currently the owner and Medical Director of the practice. He is board-certified as a Diagnostic Radiologist with sub-specialties in Orthopedic & Sports Medicine Imaging, Body MRI, and holds a Level II Cardiac CT certification. Dr. Feller is also a partner in China’s first American-owned multi-disciplinary outpatient healthcare facility, and serves as director of radiology.

After completing a Bachelor’s degree in Metallurgical Engineering and Material Science at the University of Notre Dame, Dr. Feller graduated Summa Cum Laude from Ohio State University School of Medicine, then an internship, residency, and fellowship training at Stanford University School of Medicine.

Serving as a United States Air Force (USAF) officer, Dr. Feller was the Chief of MRI at the David Grant USAF Medical Center for four years, while maintaining an academic affiliation with Stanford as an Assistant Clinical Professor in the Department of Radiology, an affiliation that lasted 15 years. Currently, Dr. Feller is an Assistant Clinical Professor at Loma Linda University’s Department of Radiology.

Dr. Feller has co-authored many peer-reviewed journal articles, and served as editor for the textbook Shoulder Magnetic Resonance Imaging. He has been invited to over 300 lectures on the subjects of orthopedic imaging, prostate cancer imaging, and body MR imaging.

Lawrence N. Tanenbaum, MD, FACR
Vice President & Medical Director Eastern Region
Director of MRI, CT and Advanced Imaging
RadNet, Inc

Dr. Tanenbaum is currently the Vice President and Medical Director for the Eastern Region and Director of MRI, CT and Advanced Imaging at RadNet, Inc., a leading provider of freestanding, fixed-site diagnostic imaging services in the United States. Prior to this role, Dr. Tanenbaum served as Associate Professor of Radiology and Director of MRI/CT & Outpatient / Advanced Imaging Development at the Icahn School of Medicine at Mount Sinai in New York.

Dr. Tanenbaum is a senior member of the American Society of Neuroradiology and a long term member of the Radiological Society of North America. He is the current President of the Eastern Society of Neuroradiology, past President of the national Clinical Magnetic Resonance Society and former Editor-in-Chief of its Journal "Vision." He is a member of the Roster of Distinguished Scientific Advisors of the RSNA as well as a number of panels and committees of the American College of Radiology.

Dr. Tanenbaum has authored approximately 100 scholarly and peer reviewed articles, continues to chair educational and academic meetings and has delivered over 1500 invited lectures around the world.

Conflict of Interest Disclosure Policy

IAME requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.

Disclosures

Dr. Feller discloses that he is a member of the Hitachi Healthcare Americas speakers bureau.

Dr. Tanenbaum discloses that he is a speaker for GE, Guerbet, Hitachi Healthcare Americas Philips Healthcare and Siemens Healthineers.

No individual at IAME who had control over the content of this program has relationships with Hitachi Healthcare Americas or any other commercial supporter.

Accreditation

The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

Radiologic Technologists:
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.

Radiology Administrators:
This course meets all CRA renewal credit criteria and has been approved for one (1) continuing education credit in the following CRA domains: Asset Resource Management (AM), Operations Management (OM) and Fiscal Management (FM).

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.

Method of Participation/Criteria for Success

CME Credits
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.

CE Credits
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.

Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.